Semtech Option Alert: Jan, 2027 $50 Calls at the Bid: 1750 vs 24 OI; Earnings 3/27 After Close [est] 

Semtech Option Alert: Jan, 2027 $50 Calls at the Bid: 1750 @ $10.25 vs 24 OI; Earnings 3/27 After Close [est] Ref=$36.54

Semtech (NASDAQ:SMTC) Azioni

Semtech

Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments' 1) Signal Integrity, 2) Advanced Protection and Sensing, 3) IoT System and 4) IoT Connected Services. The majority of the company's revenue is earned through Advanced Protection and Sensing Products segment. Geographically majority of the company's revenue is earned from Asia Pacific region.

Semtech Corp

<h3>Companies Reporting Before The Bell</h3>
• Advanced Flower Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFCG#NASDAQ">AFCG</a>) is likely to report quarterly earnings at $0.36 per share on revenue of $11.76 million. 
• Ballard Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDP#NASDAQ">BLDP</a>) is likely to report quarterly loss at $0.13 per share on revenue of $28.55 million. 
• Perma-Fix Envirn Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PESI#NASDAQ">PESI</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $15.80 million. 
• ZSPACE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) is expected to report quarterly loss at $0.09 per share on revenue of $9.61 million. 
• CION Invt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CION#NYSE">CION</a>) is likely to report quarterly earnings at $0.35 per share on revenue of $54.11 million. 
• Altisource Portfolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPS#NASDAQ">ASPS</a>) is expected to report earnings for its fourth quarter. 
• US Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) is expected to report quarterly loss at $0.08 per share on revenue of $4.54 million. 
• Akebia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $37.36 million. 
• G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) is likely to report quarterly earnings at $0.97 per share on revenue of $807.11 million. 
• Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) is projected to report earnings for its fourth quarter. 
• Apyx Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APYX#NASDAQ">APYX</a>) is projected to report quarterly loss at $0.16 per share on revenue of $13.39 million. 
• Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $8.67 million. 
• D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) is expected to report quarterly loss at $0.06 per share on revenue of $2.23 million. 
• Village Farms Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) is projected to report quarterly loss at $0.02 per share on revenue of $81.68 million. 
• Lifetime Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCUT#NASDAQ">LCUT</a>) is expected to report quarterly earnings at $0.43 per share on revenue of $204.70 million. 
• CareCloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $27.99 million. 
• Blade Air Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $50.53 million. 
• Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) is expected to report quarterly earnings at $1.50 per share on revenue of $10.26 billion. 
• Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) is estimated to report quarterly earnings at $1.50 per share on revenue of $147.53 million. 
• Cellectar Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) is estimated to report earnings for its fourth quarter. 
• Aveanna Healthcare Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAH#NASDAQ">AVAH</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $499.61 million. 
• Century Casinos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTY#NASDAQ">CNTY</a>) is projected to report quarterly loss at $0.49 per share on revenue of $142.21 million. 
• Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $25.15 million. 
• Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) is projected to report earnings for its fourth quarter. 
• Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) is expected to report earnings for its fourth quarter. 
• Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) is likely to report quarterly earnings at $0.01 per share on revenue of $76.67 million. 
• Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) is likely to report quarterly loss at $0.47 per share on revenue of $2.67 million. 
• Quoin Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNRX#NASDAQ">QNRX</a>) is likely to report earnings for its fourth quarter. 
• Xunlei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNET#NASDAQ">XNET</a>) is estimated to report earnings for its fourth quarter. 
• Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) is likely to report quarterly loss at $0.07 per share on revenue of $47.75 million. 
• Duluth Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) is estimated to report quarterly earnings at $0.11 per share on revenue of $252.86 million. 
• Weibo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WB#NASDAQ">WB</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $451.76 million. 
• Sotherly Hotels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOHO#NASDAQ">SOHO</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $42.80 million. 
<h3>Companies Reporting After The Bell</h3>
• Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $394.49 million. 
• DocuSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) is likely to report quarterly earnings at $0.85 per share on revenue of $761.31 million. 
• Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) is expected to report quarterly loss at $0.08 per share on revenue of $130.60 million. 
• Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) is likely to report quarterly earnings at $1.82 per share on revenue of $1.63 billion. 
• Frequency Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) is expected to report earnings for its third quarter. 
• Shimmick (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIM#NASDAQ">SHIM</a>) is likely to report quarterly loss at $0.35 per share on revenue of $118.90 million. 
• Transact Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TACT#NASDAQ">TACT</a>) is projected to report quarterly loss at $0.10 per share on revenue of $10.37 million. 
• Cellectis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLLS#NASDAQ">CLLS</a>) is projected to report quarterly loss at $0.21 per share on revenue of $9.09 million. 
• Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) is expected to report earnings for its fourth quarter. 
• Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) is estimated to report quarterly earnings at $0.77 per share on revenue of $253.99 million. 
• Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) is expected to report earnings for its fourth quarter. 
• Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) is likely to report quarterly loss at $0.63 per share on revenue of $3.08 million. 
• Turtle Beach (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBCH#NASDAQ">TBCH</a>) is expected to report quarterly earnings at $1.21 per share on revenue of $161.36 million. 
• FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) is expected to report quarterly loss at $0.04 per share on revenue of $29.02 million. 
• aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) is projected to report earnings for its fourth quarter. 
• Pangaea Logistics Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANL#NASDAQ">PANL</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $142.61 million. 
• PSQ Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) is projected to report quarterly loss at $0.42 per share on revenue of $7.70 million. 
• VAALCO Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGY#NYSE">EGY</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $108.91 million. 
• Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) is expected to report quarterly loss at $0.18 per share on revenue of $12 thousand. 
• Vuzix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $2.77 million. 
• WM Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $46.00 million. 
• Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $250.17 million. 
• Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) is estimated to report quarterly earnings at $0.76 per share on revenue of $276.46 million. 
• OPAL Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPAL#NASDAQ">OPAL</a>) is likely to report quarterly earnings at $0.35 per share on revenue of $92.09 million. 
• Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) is expected to report quarterly loss at $0.14 per share on revenue of $30.77 million. 
• HeartBeam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>) is estimated to report earnings for its fourth quarter. 
• Karat Packaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRT#NASDAQ">KRT</a>) is expected to report quarterly earnings at $0.36 per share on revenue of $102.27 million. 
• AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) is expected to report earnings for its fourth quarter. 
• PLBY Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBY#NASDAQ">PLBY</a>) is likely to report quarterly loss at $0.11 per share on revenue of $14.30 million. 
• Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) is projected to report quarterly loss at $1.11 per share on revenue of $23.52 million. 
• Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $22.29 million. 
• Xponential Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $81.42 million. 
• ZOMEDICA CORP COM (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZOM#AMEX">ZOM</a>) is likely to report quarterly loss at $0.01 per share on revenue of $8.10 million. 
• GrowGeneration (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) is projected to report quarterly loss at $0.11 per share on revenue of $42.21 million. 
• Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) is likely to report quarterly earnings at $0.08 per share on revenue of $40.13 million. 
• PagerDuty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $119.53 million. 
• EverCommerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVCM#NASDAQ">EVCM</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $170.48 million. 
• Drilling Tools Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTI#NASDAQ">DTI</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $36.08 million. 
• AlTi Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $74.60 million. 
• Origin Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGN#NASDAQ">ORGN</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $9.08 million. 
• Heritage Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGBL#NASDAQ">HGBL</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $12.30 million. 
• Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) is likely to report quarterly loss at $0.39 per share on revenue of $232.91 million. 
• Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $348.33 million. 
• ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) is projected to report earnings for its first quarter. 
• Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) is estimated to report quarterly earnings at $7.13 per share on revenue of $3.47 billion. 
• Portman Ridge Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTMN#NASDAQ">PTMN</a>) is expected to report quarterly earnings at $0.65 per share on revenue of $15.33 million. 
• Logan Ridge Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRFC#NASDAQ">LRFC</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $5.00 million. 
• Joint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $28.95 million. 
• BuzzFeed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) is likely to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ACTG

AFCG

AGRO

AKBA

ALLO

ALTI

APYX

ASPS

ATYR

AUID

AVAH

BAER

BEAT

BLDE

BLDP

BLNK

BZFD

CCLD

CION

CLLS

CLRB

CNTY

DLTH

DOCU

EVCM

EVOK

FEIM

FUTU

GIII

GRWG

GURU

HGBL

JYNT

LCUT

LRFC

MAPS

MCRB

NOTE

NYXH

OPAL

ORGN

PANL

PESI

PHAR

PLBY

PRPL

PSQH

PTMN

QBTS

QNRX

RBRK

RGNX

SHIM

SKLZ

SMTC

SOHO

TACT

TBCH

TTAN

ULTA

USEG

VERI

VUZI

XNET

XPOF

ZSPC

ZUMZ

Earnings Scheduled For March 13, 2025

WIIM

AMBA

DIOD

KOPN

RMBS

Shares of chip stocks are trading lower amid recession worries due to uncertainty regarding tariffs and trade policy. President Trump said there is a "period of transition."

AAOI

ADTN

ALAB

AMAT

ANET

ASML

ATGL

BBAI

CAMT

CIEN

CIFR

COHR

COMM

CRDO

DELL

FLEX

IONQ

KLAC

LITE

LRCX

MPWR

NVMI

PSTG

SMCI

SNOW

TWLO

WULF

Shares of companies with the broader tech sector are trading lower amid overall market weakness following a rise in Treasury yields. Investors may be evaluating ongoing global tension related to tariffs and conflict.

AOSL

ENTG

FORM

MTSI

OLED

QCOM

Shares of semiconductor stocks are trading lower after a Wall Street Journal report revealed that Chinese buyers have been ordering Nvidia chips despite U.S. restrictions. Additionally, President Trump confirmed Mar. 4 tariffs, which could drive further trade uncertainty.

INTC

MRVL

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

SWKS

Shares of chip stocks are trading higher, rebounding after falling this week in sympathy with NVIDIA.

ACMR, ALAB, AMAT, AMBA, AMD, AMKR, AOSL, ARM, ARQQ, ASML, ASX, ATO, CAMT, CRDO, ENTG, FORM, HIMX, ICHR, INTC, KLAC, KLIC, LAES, LRCX, MKSI, MTSI, MU, MXL, NN, NVDA, NVMI, NVTS, ONDS, ONTO, QUIK, RGTI, RMBS, SITM, SKYT, SMH, SMTC, SOXX, STM, TSEM, TSM, UCTT, VUZI, WOLF

AMCR

AMKR

ARQQ

HIMX

ICHR

KLIC

MKSI

NVDA

NVTS

ONDS

ONTO

QUIK

RGTI

SITM

SKYT

TSEM

UCTT

Shares of semiconductor companies are trading lower in sympathy with Nvidia, which reversed amid a possible selloff after reporting Q4 financial results.

ACMR

LAES

WOLF

Shares of semiconductor companies are trading higher in anticipation of Nvidia's Q4 earnings which are scheduled to be reported after hours today. Additionally, large AI investment announcements from Apple and Meta this week may be buoying the industry.

Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has been the poster child of the AI revolution, but cracks are showing as supplier delays and technical indicators <a href="https://www.benzinga.com/quote/NVDA/news">flash warning signs</a>. 
Analyst Beth Kindig, typically bullish on Nvidia, recently sounded the alarm after <a href="https://io-fund.com/semiconductors/supply-chain/nvidia-gb200-delays-mixed-signals-nvda-stock-analysis">scrutinizing supplier commentary</a>. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Key suppliers for Nvidia's GB200 NVL systems are not exactly inspiring confidence in Q1 and fiscal year guidance. Instead, a few have actually lowered guidance. Tomorrow, keep an eye on your inboxes as I break down the mixed signals that I'm hearing from Nvidia suppliers for the…
&mdash; Beth Kindig (@Beth_Kindig) <a href="https://twitter.com/Beth_Kindig/status/1893326435768496356?ref_src=twsrc%5Etfw">February 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The takeaway? The GB200 rollout might not be as smooth as expected and NVDA stock could feel the heat.
<h2 class="wp-block-heading">Supplier Red Flags: Delays Mount</h2>
Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), a key Nvidia partner, trimmed its fiscal 2025 revenue guide, citing Blackwell GPU delays. CEO Charles Liang had previously expected 30% of racks to use direct liquid cooling (DLC) by mid-2025. That target has now quietly slipped to early 2026. 
Worse, SMCI admitted they can't ship Blackwell NVL systems in volume for the March quarter—a red flag for Nvidia's near-term growth.
Vertiv Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>), another Nvidia ecosystem player, reported strong fourth quarter results but guided for softer first quarter growth, blaming &#8220;timing differences&#8221; in AI shipments. Meanwhile, PCIe 6.0 and PMIC suppliers, crucial for Blackwell systems, now expect volume deployments only in the back half of the year. 
Semtech's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) decision to pull guidance on active copper cabling further reinforces the narrative of a bumpy road.
Read Also: <a href="https://www.benzinga.com/25/02/43908370/amd-reshapes-strategy-plans-4-billion-data-center-asset-sale-while-doubling-down-on-gpus">AMD Reshapes Strategy, Plans $4 Billion Data Center Asset Sale While Doubling Down on GPUs</a>
<h2 class="wp-block-heading">NVDA Stock Technicals: Momentum Fades</h2>
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24081439/Screenshot-2025-02-24-at-6.44.28-PM.png" alt="" class="wp-image-795366" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24081439/Screenshot-2025-02-24-at-6.44.28-PM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24081439/Screenshot-2025-02-24-at-6.44.28-PM-300x233.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
NVDA stock has cooled off year-to-date, down 2.83%, despite a stellar 69.93% gain over the past year. The stock is struggling near its 50-day moving average, a key technical level that often signals whether bullish momentum can continue or falter. 
Trading volumes have thinned and the relative strength index (RSI) is around 50, indicating fading buying pressure. If NVDA stock breaks below $110, it could trigger a deeper pullback toward the $100 psychological support—a level that aligns with Kindig's view of a potential &#8220;buying opportunity&#8221; if the stock dips further.
<h2 class="wp-block-heading">Q4 Earnings Catalyst Or Reality Check?</h2>
With <a href="https://www.benzinga.com/quote/NVDA/earnings">earnings on deck</a> (reports fourth quarter after market close on Wednesday), Nvidia faces a moment of truth. 
If management acknowledges the supplier delays, the stock could slip further. However, strength from Hopper and B200 systems might offset the near-term Blackwell hiccup. 
Investors should brace for volatility. Nvidia's AI dominance isn't in question, but the road ahead looks bumpier than bulls might like.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43905646/nvidia-set-for-clear-beat-and-raise-special-as-ai-demand-surges-says-dan-ives">Nvidia Set For &#8216;Clear Beat And Raise Special&#8217; As AI Demand Surges, Says Dan Ives</a></li>
</ul>

Analyst Color

Long Ideas

Technicals

Analyst Ratings

Tech

Trading Ideas

Nvidia Stock Offers 'Buying Opportunity' Below $100 - Supplier Woes Suggest Caution, Says Analyst

News

General

Internet Of Things Systems Provider Semtech Introduces New Electrostatic Discharge (ESD) Protection For Automotive Ethernet Applications

<h3>Gainers</h3>
<ul>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock increased by 46.7% to $0.09 during Monday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares increased by 31.53% to $0.54. The market value of their outstanding shares is at $20.4 million. </li>
<li>Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) shares increased by 22.97% to $317.56. The company's market cap stands at $15.8 billion. The company's, Q4 earnings came out today. </li>
<li>Neonode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEON#NASDAQ">NEON</a>) shares rose 16.13% to $10.15. The company's market cap stands at $170.3 million. </li>
<li>Trident Digital Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) stock moved upwards by 11.11% to $0.95. The company's market cap stands at $61.3 million. </li>
<li>Iveda Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVDA#NASDAQ">IVDA</a>) stock increased by 9.26% to $3.42. The company's market cap stands at $9.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) shares decreased by 26.4% to $40.15 during Monday's pre-market session. The company's market cap stands at $3.4 billion. </li>
<li>Nortech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) stock declined by 8.91% to $9.61. The market value of their outstanding shares is at $26.4 million. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) shares decreased by 8.78% to $2.08. The company's market cap stands at $195.1 million. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) stock fell 7.98% to $2.18. The market value of their outstanding shares is at $28.8 million. </li>
<li>Rimini Street (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMNI#NASDAQ">RMNI</a>) shares decreased by 7.2% to $2.58. The company's market cap stands at $234.5 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNHP#NASDAQ">SLNHP</a>) stock fell 6.9% to $8.1. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMOD

BNAI

IVDA

MNDY

NEON

NSYS

REKR

RMNI

SLNHP

TDTH

12 Information Technology Stocks Moving In Monday's Pre-Market Session

U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 150 points on Monday.
The Dow traded up 0.40% to 44,482.54 while the NASDAQ gained 1.16% to 19,750.22. The S&amp;P 500 also rose, gaining, 0.75% to 6,071.29.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a>
Leading and Lagging Sectors Energy shares surged by 2% on Monday.
In trading on Monday, financial shares fell by 0.6%.
Top Headline
U.S. consumer inflation expectations for the year ahead came in steady for a third straight month at 3% in January.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>SpringWorks Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) shares shot up 36% to $54.85 after announcing Merck KGaA is in advanced discussions to acquire the company.</li>
<li>Shares of Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>)got a boost, surging 42% to $5.78 after the company announced it received FDA fast-track designation for eRapa.</li>
<li>monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) shares were also up, gaining 28% to $331.46 after the company reported better-than-expected fourth-quarter financial results and first-quarter revenue outlook.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) shares dropped 59% to $3.1893. On Friday, Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and stiffening of the lung tissue.</li>
<li>Shares of Manhattan Associates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) were down 11% to $179.24. The company announced its president and CEO Eddie Capel will retire.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) was down, falling 31% to $37.60 after Needham cut its price target on the stock from $74 to $54.</li>
</ul>
Commodities In commodity news, oil traded up 1.7% to $72.22 while gold traded up 1.7% at $2,935.20.
Silver traded up 0.2% to $32.515 on Monday, while copper rose 2.6% to $4.7060.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.58%, Germany's DAX 40 rose 0.57% and France's CAC 40 rose 0.52%. Spain's IBEX 35 Index rose 0.16%, while London's FTSE 100 rose 0.77%.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.04%, China's Shanghai Composite Index climbing 0.56%, Hong Kong's Hang Seng Index gaining 1.84% and India's BSE Sensex falling 0.70%.
Economics
U.S. consumer inflation expectations for the year ahead came in steady for a third straight month at 3% in January.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

Equities

Eurozone

Commodities

Markets

BDRX

MANH

PLRX

SWTX

Crude Oil Rises Sharply; Manhattan Associates Shares Slide

Stifel analyst Tore Svanberg maintains Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Buy and lowers the price target from $75 to $70.

Price Target

Stifel Maintains Buy on Semtech, Lowers Price Target to $70

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Monday.
The Dow traded up 0.07% to 44,332.96 while the NASDAQ gained 1.06% to 19,729.75. The S&amp;P 500 also rose, gaining, 0.55% to 6,059.14.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a>
Leading and Lagging Sectors Energy shares surged by 1.8% on Monday.
In trading on Monday, financial shares fell by 1%.
Top Headline
Shares of ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) dipped around 8% on Monday after the company posted downbeat quarterly results.
The company reported a fiscal fourth-quarter 2024 revenue decline of 15% year-on-year to $1.72 billion, missing the analyst consensus estimate of $1.76 billion.
The adjusted EPS of $0.95 missed the analyst consensus estimate of $0.97.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>SpringWorks Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) shares shot up 30% to $52.46 after announcing Merck KGaA is in advanced discussions to acquire the company.</li>
<li>Shares of Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>)got a boost, surging 67% to $6.80 after the company announced it received FDA fast-track designation for eRapa.</li>
<li>monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) shares were also up, gaining 29% to $334.00 after the company reported better-than-expected fourth-quarter financial results and first-quarter revenue outlook.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) shares dropped 61% to $3.0089. On Friday, Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and stiffening of the lung tissue.</li>
<li>Shares of Ubiquiti Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UI#NYSE">UI</a>) were down 12% to $345.09. Barclays analyst Tim Long maintained Ubiquiti with an Underweight and lowered the price target from $236 to $222.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) was down, falling 31% to $37.62 after Needham cut its price target on the stock from $74 to $54.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $71.78 while gold traded up 1.7% at $2,937.40.
Silver traded up 0.7% to $32.670 on Monday, while copper rose 2.2% to $4.6875.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.60%, Germany's DAX 40 rose 0.61% and France's CAC 40 rose 0.36%. Spain's IBEX 35 Index rose 0.09%, while London's FTSE 100 rose 0.88%.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.04%, China's Shanghai Composite Index climbing 0.56%, Hong Kong's Hang Seng Index gaining 1.84% and India's BSE Sensex falling 0.70%.
Economics
Data on US consumer inflation expectations will be released today
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

Intraday Update

Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 100 points on Monday.
Following the market opening Monday, the Dow traded up 0.24% to 44,407.91 while the NASDAQ gained 0.89% to 19,696.41. The S&amp;P 500 also rose, gaining, 0.43% to 6,051.88.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a>
Leading and Lagging Sectors Information technology shares surged by 1.5% on Monday.
In trading on Monday, real estate shares fell by 0.7%.
Top Headline
Shares of McDonald's Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) gained around 5% on Monday following the release of fourth-quarter results.
The company reported a fourth-quarter sales decline of 0.3% year-on-year to $6.388 billion, missing the analyst consensus estimate of $6.442 billion. Adjusted EPS of $2.83 was in line with the analyst consensus estimate.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares shot up 107% to $0.8625.</li>
<li>Shares of Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>)got a boost, surging 70% to $6.93 after the company announced it received FDA fast-track designation for eRapa.</li>
<li>Global Star Acquisition, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLST#NASDAQ">GLST</a>) shares were also up, gaining 58% to $17.32.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) shares dropped 60% to $3.1075. On Friday, Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and stiffening of the lung tissue.</li>
<li>Shares of FBS Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBGL#NASDAQ">FBGL</a>) were down 33% to $1.2050.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) was down, falling 31% to $37.46 after Needham cut its price target on the stock from $74 to $54.</li>
</ul>
Commodities In commodity news, oil traded up 1.4% to $71.99 while gold traded up 1.5% at $2,931.10.
Silver traded up 0.6% to $32.635 on Monday, while copper rose 2% to $4.6820.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.5%, Germany's DAX 40 rose 0.6% and France's CAC 40 rose 0.3%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 rose 0.8%.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.04%, China's Shanghai Composite Index climbing 0.56%, Hong Kong's Hang Seng Index gaining 1.84% and India's BSE Sensex falling 0.70%.
Economics
Data on US consumer inflation expectations will be released today
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

FBGL

GLST

Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results

Shares of Macom Technology Solutions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) came under pressure, despite in-line fiscal first-<a href="https://www.benzinga.com/topic/semiconductors">quarter results and outlook</a>.
Rival Semtech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) disclosed lower IC (integrated circuit) sales into Active Copper Cables, according to Northland Capital Partners.
The Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590c74bd290fa70001c93005/tim-savageaux">Analyst Tim Savageaux</a> upgraded the rating for Macom Technology Solutions from Market Perform to Outperform, while raising the price target to $140.
The Thesis: The company's first-quarter revenue grew by 9% sequentially and 39% year-on-year to $218.1 million, Savageaux said in the upgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The sequential growth in revenues was driven by Datacom, while year-on-year growth was led by an around 80% increase in Telecom revenues due to the Wolfspeed acquisition and strong growth in Industrial/Defense revenues, he added.
"MTSI noted its third consecutive quarter with a 1.10 book to bill, the analyst stated. "MTSI noted expectations for an expansion of its AI Datacom customer base at 800G, which to date has been focused on major China module makers, as well as a ramp in solutions supporting 1.6T connectivity over the next Qs," he further wrote.
"We look to take advantage of any weakness given strong bookings and multiple growth vectors including AI Optical, Satcom and Defense," the analyst stated.
Price Action: Shares of Macom Technology Solutions had declined by 0.76% to $126.24 at the time of publication on Monday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42953261/nvidia-broadcom-and-marvell-positioned-for-growth-as-ai-demand-drives-semiconductor-momentum">Nvidia, Broadcom, Marvell Positioned For Growth As AI Demand Drives Semiconductor Momentum</a></li>
</ul>
Image: Shutterstock

Topics

Macom Technology Solutions Is Poised For AI-Driven Revenue Growth: Analyst

Piper Sandler analyst Harsh Kumar reiterates Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Overweight and lowers the price target from $75 to $55.

Reiteration

Piper Sandler Reiterates Overweight on Semtech, Lowers Price Target to $55

Semtech shares are trading lower after Needham cut its price target on the stock from $74 to $54.

U.S. stock futures were higher this morning, with the Dow Jones futures gaining <a href="https://www.benzinga.com/quote/TSLA">around 150 points on Monday</a>.
Shares of Tesla, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell in today's <a href="https://www.benzinga.com/quote/TSLA">pre-market trading</a>.
Tesla CEO Elon Musk and Vice President of Finance Sendil Palani addressed allegations of the EV company evading taxes in posts on X over the weekend. The company did not evade tax but carried it forward as per an Internal Revenue Service (IRS) provision, they said.
Tesla shares fell 1.2% to $357.16 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) dipped 54.5% to $3.54 in pre-market trading after the company issued an update on BEACON-IPF, a Phase 2b/3 trial in patients with idiopathic pulmonary fibrosis.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) shares tumbled 25.2% to $40.75 in pre-market trading. Semtech shares fell around 10% on Friday after Baird cut its price target on the stock from $80 to $60.</li>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) declined 20.2% to $0.91 in pre-market trading after falling more than 5% on Friday.</li>
<li>Replimune Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) fell 19.6% to $11.21 in pre-market trading. Replimune announced inducement grants under Nasdaq Listing Rule 5635(c)(4).     </li>
<li>Maze Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) fell 9.5% to $12.11 in pre-market trading. Maze Therapeutics shares gained around 3% on Friday after the company announced that the first patient has been dosed in the company&#8217;s Phase 2 clinical trial, the HORIZON Study, of MZE829 in patients with APOL1 kidney disease.</li>
<li>Dogness (International) Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) fell 6.6% to $33.00 in pre-market trading.</li>
<li>The Manitowoc Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTW#NYSE">MTW</a>) shares dipped 6.4% to $9.12 in pre-market trading.</li>
<li>Option Care Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>) fell 6% to $29.13 in pre-market trading.</li>
<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) fell 3.2% to $125.52 in pre-market trading.</li>
<li>ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) shares declined 2.1% to $50.20 in pre-market trading ahead of quarterly earnings.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a></li>
</ul>

Pre-Market Outlook

DOGZ

Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Comments

Semtech

Unusual Options Activity for

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO